New piperidine derivative DTPEP acts as dual ‐acting anti‐breast cancer agent by targeting ERα and downregulating PI3K/Akt‐PKCα leading to caspase‐dependent apoptosis

ConclusionsWe identified a new dual ‐acting anti‐breast cancer molecules as a proof of concept which is capable of targeting both ER‐positive and ER‐negative breast cancer.

Source: Cell Proliferation - November 14, 2018 Category: Cytology Authors: A. Arun, M.I. Ansari, P. Popli, S. Jaiswal, A.K. Mishra, A. Dwivedi, K. Hajela, R. Konwar Tags: ORIGINAL ARTICLE Source Type: research